Cargando…

Breast cancer survival after mammography dissemination in Brazil: a population-based analysis of 2,715 cases

BACKGROUND: This study aims to assess breast cancer survival rates after one decade of mammography in a large urban area of Brazil. METHODS: It is a population-based retrospective cohort of women with breast cancer in Campinas, São Paulo, from 2010 to 2014. Age, vital status and stage were accessed...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Juliana O., Machado, Beatriz F., Cardoso-Filho, Cassio, Nativio, Juliana, Cabello, Cesar, Vale, Diama B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696793/
https://www.ncbi.nlm.nih.gov/pubmed/38049765
http://dx.doi.org/10.1186/s12905-023-02803-4
_version_ 1785154645204664320
author Fernandes, Juliana O.
Machado, Beatriz F.
Cardoso-Filho, Cassio
Nativio, Juliana
Cabello, Cesar
Vale, Diama B.
author_facet Fernandes, Juliana O.
Machado, Beatriz F.
Cardoso-Filho, Cassio
Nativio, Juliana
Cabello, Cesar
Vale, Diama B.
author_sort Fernandes, Juliana O.
collection PubMed
description BACKGROUND: This study aims to assess breast cancer survival rates after one decade of mammography in a large urban area of Brazil. METHODS: It is a population-based retrospective cohort of women with breast cancer in Campinas, São Paulo, from 2010 to 2014. Age, vital status and stage were accessed through the cancer and mortality registry, and patients records. Statistics used Kaplan–Meier, log-rank and Cox's regression. RESULTS: Out of the 2,715 cases, 665 deaths (24.5%) were confirmed until early 2020. The mean age at diagnosis was 58.6 years. Women 50–69 years were 48.0%, and stage I the most frequent (25.0%). The overall mean survival was 8.4 years (8.2–8.5). The 5-year survival (5yOS) for overall, 40–49, 50–59, 60–69, 70–79 years was respectively 80.5%, 87.7%, 83.7%, 83.8% and 75.5%. The 5yOS for stages 0, I, II, III and IV was 95.2%, 92.6%, 89.4%, 71.1% and 47.1%. There was no significant difference in survival in stage I or II (p = 0.058). Compared to women 50–59 years, death's risk was 2.3 times higher for women 70–79 years and 26% lower for women 40–49 years. Concerning stage I, the risk of death was 1.5, 4.1 and 8.6 times higher, and 34% lower, respectively, for stage II, III, IV and 0. CONCLUSIONS: In Brazil, breast cancers are currently diagnosed in the early stages, although advanced cases persist. Survival rates may reflect improvements in screening, early detection and treatment. The results can reflect the current status of other regions or countries with similar health care conditions.
format Online
Article
Text
id pubmed-10696793
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106967932023-12-06 Breast cancer survival after mammography dissemination in Brazil: a population-based analysis of 2,715 cases Fernandes, Juliana O. Machado, Beatriz F. Cardoso-Filho, Cassio Nativio, Juliana Cabello, Cesar Vale, Diama B. BMC Womens Health Research BACKGROUND: This study aims to assess breast cancer survival rates after one decade of mammography in a large urban area of Brazil. METHODS: It is a population-based retrospective cohort of women with breast cancer in Campinas, São Paulo, from 2010 to 2014. Age, vital status and stage were accessed through the cancer and mortality registry, and patients records. Statistics used Kaplan–Meier, log-rank and Cox's regression. RESULTS: Out of the 2,715 cases, 665 deaths (24.5%) were confirmed until early 2020. The mean age at diagnosis was 58.6 years. Women 50–69 years were 48.0%, and stage I the most frequent (25.0%). The overall mean survival was 8.4 years (8.2–8.5). The 5-year survival (5yOS) for overall, 40–49, 50–59, 60–69, 70–79 years was respectively 80.5%, 87.7%, 83.7%, 83.8% and 75.5%. The 5yOS for stages 0, I, II, III and IV was 95.2%, 92.6%, 89.4%, 71.1% and 47.1%. There was no significant difference in survival in stage I or II (p = 0.058). Compared to women 50–59 years, death's risk was 2.3 times higher for women 70–79 years and 26% lower for women 40–49 years. Concerning stage I, the risk of death was 1.5, 4.1 and 8.6 times higher, and 34% lower, respectively, for stage II, III, IV and 0. CONCLUSIONS: In Brazil, breast cancers are currently diagnosed in the early stages, although advanced cases persist. Survival rates may reflect improvements in screening, early detection and treatment. The results can reflect the current status of other regions or countries with similar health care conditions. BioMed Central 2023-12-04 /pmc/articles/PMC10696793/ /pubmed/38049765 http://dx.doi.org/10.1186/s12905-023-02803-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Fernandes, Juliana O.
Machado, Beatriz F.
Cardoso-Filho, Cassio
Nativio, Juliana
Cabello, Cesar
Vale, Diama B.
Breast cancer survival after mammography dissemination in Brazil: a population-based analysis of 2,715 cases
title Breast cancer survival after mammography dissemination in Brazil: a population-based analysis of 2,715 cases
title_full Breast cancer survival after mammography dissemination in Brazil: a population-based analysis of 2,715 cases
title_fullStr Breast cancer survival after mammography dissemination in Brazil: a population-based analysis of 2,715 cases
title_full_unstemmed Breast cancer survival after mammography dissemination in Brazil: a population-based analysis of 2,715 cases
title_short Breast cancer survival after mammography dissemination in Brazil: a population-based analysis of 2,715 cases
title_sort breast cancer survival after mammography dissemination in brazil: a population-based analysis of 2,715 cases
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696793/
https://www.ncbi.nlm.nih.gov/pubmed/38049765
http://dx.doi.org/10.1186/s12905-023-02803-4
work_keys_str_mv AT fernandesjulianao breastcancersurvivalaftermammographydisseminationinbrazilapopulationbasedanalysisof2715cases
AT machadobeatrizf breastcancersurvivalaftermammographydisseminationinbrazilapopulationbasedanalysisof2715cases
AT cardosofilhocassio breastcancersurvivalaftermammographydisseminationinbrazilapopulationbasedanalysisof2715cases
AT nativiojuliana breastcancersurvivalaftermammographydisseminationinbrazilapopulationbasedanalysisof2715cases
AT cabellocesar breastcancersurvivalaftermammographydisseminationinbrazilapopulationbasedanalysisof2715cases
AT valediamab breastcancersurvivalaftermammographydisseminationinbrazilapopulationbasedanalysisof2715cases